Natalia Fedoryszak-Kuśka Selected Research

3',4'- ethylenedioxyphenyl- 2- palmitoylamino- 3- pyrrolidino- 1- propanol

1/2016

Glucosylceramide synthase inhibitors D-PDMP and D-EtDO-P4 decrease the GM3 ganglioside level, differ in their effects on insulin receptor autophosphorylation but increase Akt1 kinase phosphorylation in human hepatoma HepG2 cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Natalia Fedoryszak-Kuśka Research Topics

Disease

1	Hepatocellular Carcinoma (Hepatoma) 01/2016

Drug/Important Bio-Agent (IBA)

1	ceramide glucosyltransferaseIBA 01/2016
1	RV 538 (PDMP)IBA 01/2016
1	3',4'- ethylenedioxyphenyl- 2- palmitoylamino- 3- pyrrolidino- 1- propanolIBA 01/2016
1	G(M3) GangliosideIBA 01/2016
1	Phosphotransferases (Kinase)IBA 01/2016
1	Insulin ReceptorIBA 01/2016